An observational study in Dementia and Memory Disorders in Old Age, sponsored by Ochsner Health System. Terminated at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-09-16.
Sponsored by Ochsner Health System · Observational
To investigate the efficacy of an individualized treatment plan delivered through remote technology along with enhanced staff training within a supervised memory unit on patient outcome, care quality, health care utilization/cost, and staff burden. Remote monitoring of activity data will also be explored.
2,172 studies on the registry are indexed under Dementia; 540 are open to participants now.
This study's enrollment of 89 is below the median of 250 across 482 observational studies indexed under Dementia.
Browse Dementia studies →Ochsner Health System is the lead sponsor of 54 studies on the registry; 7 are open to participants now.
Of its 7 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Residents living on the memory care unit will have pre diagnosed advanced dementia or Alzheimer's disease. Subjects will have diminished or no capacity and will require a legally authorized representative.
Inclusion Criteria:
Residents on a locked memory care unit in southeastern Louisiana will be enrolled. Engaged family members and staff will also consent to provide qualitative information on the resident.
Behavioral: Individualized Care Plan
Medical, neuropsychological, and social assessment of patient's cognitive, behavioral, medical, and environmental needs with a focus on improving quality of life, reducing health care utilization, and improving staff/family caregiving burden along with a specific plan to address and monitor identified patient and staff/facility needs
Mortality/Survival Rate
Time frame: through study completion, an average of 1 year
Quality of Life Scale (QoL)
Neuropsychiatric/behavioral symptoms
Time frame: through study completion, an average of 1 year
Fall Incidence
Neuropsychiatric/behavioral symptoms
Time frame: through study completion, an average of 1 year
Zarit Caregiver Burden
Family burden
Time frame: through study completion, an average of 1 year
Patient Care Team Burden Scale (PCTB)
staff caregiver burden
Time frame: through study completion, an average of 1 year
Healthcare Utilization
Number of visits to hospital or clinic
Time frame: through study completion, an average of 1 year
Fitbit Charge HR activity and sleep data
Average daily steps, minutes asleep
Time frame: through study completion, an average of 1 year
Plan to share: No
No publications or documents are linked to this record.
This study is terminated, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ochsner Health System